Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1. (Q46239798)
Jump to navigation
Jump to search
scientific article published on 7 November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1. |
scientific article published on 7 November 2013 |
Statements
1 reference
Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1. (English)
1 reference
Scott Gettinger
1 reference
F Stephen Hodi
1 reference
Holbrook Kohrt
1 reference
Marcin Kowanetz
1 reference
John Powderly
1 reference
Hartmut Koeppen
1 reference
Jeffrey A Sosman
1 reference
Cristina Cruz
1 reference
Yuanyuan Xiao
1 reference
Ahmad Mokatrin
1 reference
Gregg Fine
1 reference
Daniel S Chen
1 reference
7 November 2013
1 reference
1 reference
1
1 reference
Suppl 1
1 reference
O12-O12
1 reference
1 November 2013
1 reference
Identifiers
1 reference
1 reference